NMD Pharma
NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases.
$80M Series B+ ·
Led by Jeito Capital · Source: fundraisingfox.com
All 2 rounds ↓Signals
X account@NMDPharma · created Aug 20, 2021 (5 years old) · 155 followers
Website registeredJun 2, 2014 (12 years old)
TIMELINE · MONEY RAISED
NMD Pharma | 3160 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $80M | fundraisingfox.com | ||
| Series A | undisclosed | novoholdings.dk |
Timeline
- X account created
- Website created
Founders and team
- AFAntonia Felicia Ellison Founder
CE
Claus Elsborg Olesen FounderOB
Ole Bækgaard Nielsen FounderTH
Thomas Holm Pedersen CEOAD
Ana de Vera CMODB
Daniel Brennan Senior Vice President, Corporate and Commercial StrategyJA
Jorge A. Quiroz Executive Vice President & Chief Medical OfficerMB
Morten Bull General Counsel
Investors
IInkeflead investor
JJeito Capitallead investor
LLundbeckfonden Emerge
NNovo Holdings
RRoche Venture Fundlead investor
Companies like NMD Pharma
AAugustine Therapeutics$85M Series A · Mar 2025
EEvolyra TherapeuticsSeed · Apr 2026
TTribune Therapeutics ABSeries A · Mar 2025
PProteinQure$11M Series A · May 2025
PPathalysSeries B+ · Aug 2024
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
Other companies backed by Jeito Capital
BBionyra$165M Series A · Jun 2026
AAzafaros$150M Series B+ · May 2025
AAugustine Therapeutics$85M Series A · Mar 2025
CCatalYm$150M Series B+ · Jul 2024
HHI-Bio$95M Series B+ · Jan 2024
PPulmocide$52M Series B+ · Dec 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nmd-pharma (get a free API key).